The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global In Vitro Diagnostics (IVD) Quality Control Product market was valued at US$ 776 million in 2023 and is anticipated to reach US$ 918.2 million by 2030, witnessing a CAGR of 2.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostics (IVD) Quality Control Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostics (IVD) Quality Control Product.
Report Scope
The In Vitro Diagnostics (IVD) Quality Control Product market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vitro Diagnostics (IVD) Quality Control Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Diagnostics (IVD) Quality Control Product companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Randox Laboratories
- Roche Diagnostics
- Abbott Diagnostics
- Helena Laboratories
- Seracare Life Sciences
- Technopath Clinical Diagnostics
- Sun Diagnostics
- Zeptometrix Corporation
- ISOLAB
- Sysmex Corporation
- Fortress Diagnostics
- Meril Life Sciences
- Multiplicom
- Future Diagnostics Solutions
- Surmodics
Segment by Type
- Quality Control Products
- Quality Assurance Services
- Data Management Solutions
Segment by Application
- Clinical Chemistry
- Immunochemistry
- Hematology
- Molecular Diagnostics
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Diagnostics (IVD) Quality Control Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Diagnostics (IVD) Quality Control Product Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Quality Control Products
1.2.3 Quality Assurance Services
1.2.4 Data Management Solutions
1.3 Market by Application
1.3.1 Global In Vitro Diagnostics (IVD) Quality Control Product Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Chemistry
1.3.3 Immunochemistry
1.3.4 Hematology
1.3.5 Molecular Diagnostics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostics (IVD) Quality Control Product Market Perspective (2019-2030)
2.2 In Vitro Diagnostics (IVD) Quality Control Product Growth Trends by Region
2.2.1 Global In Vitro Diagnostics (IVD) Quality Control Product Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In Vitro Diagnostics (IVD) Quality Control Product Historic Market Size by Region (2019-2024)
2.2.3 In Vitro Diagnostics (IVD) Quality Control Product Forecasted Market Size by Region (2025-2030)
2.3 In Vitro Diagnostics (IVD) Quality Control Product Market Dynamics
2.3.1 In Vitro Diagnostics (IVD) Quality Control Product Industry Trends
2.3.2 In Vitro Diagnostics (IVD) Quality Control Product Market Drivers
2.3.3 In Vitro Diagnostics (IVD) Quality Control Product Market Challenges
2.3.4 In Vitro Diagnostics (IVD) Quality Control Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Diagnostics (IVD) Quality Control Product Players by Revenue
3.1.1 Global Top In Vitro Diagnostics (IVD) Quality Control Product Players by Revenue (2019-2024)
3.1.2 Global In Vitro Diagnostics (IVD) Quality Control Product Revenue Market Share by Players (2019-2024)
3.2 Global In Vitro Diagnostics (IVD) Quality Control Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Diagnostics (IVD) Quality Control Product Revenue
3.4 Global In Vitro Diagnostics (IVD) Quality Control Product Market Concentration Ratio
3.4.1 Global In Vitro Diagnostics (IVD) Quality Control Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostics (IVD) Quality Control Product Revenue in 2023
3.5 In Vitro Diagnostics (IVD) Quality Control Product Key Players Head office and Area Served
3.6 Key Players In Vitro Diagnostics (IVD) Quality Control Product Product Solution and Service
3.7 Date of Enter into In Vitro Diagnostics (IVD) Quality Control Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Diagnostics (IVD) Quality Control Product Breakdown Data by Type
4.1 Global In Vitro Diagnostics (IVD) Quality Control Product Historic Market Size by Type (2019-2024)
4.2 Global In Vitro Diagnostics (IVD) Quality Control Product Forecasted Market Size by Type (2025-2030)
5 In Vitro Diagnostics (IVD) Quality Control Product Breakdown Data by Application
5.1 Global In Vitro Diagnostics (IVD) Quality Control Product Historic Market Size by Application (2019-2024)
5.2 Global In Vitro Diagnostics (IVD) Quality Control Product Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In Vitro Diagnostics (IVD) Quality Control Product Market Size (2019-2030)
6.2 North America In Vitro Diagnostics (IVD) Quality Control Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In Vitro Diagnostics (IVD) Quality Control Product Market Size by Country (2019-2024)
6.4 North America In Vitro Diagnostics (IVD) Quality Control Product Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Diagnostics (IVD) Quality Control Product Market Size (2019-2030)
7.2 Europe In Vitro Diagnostics (IVD) Quality Control Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In Vitro Diagnostics (IVD) Quality Control Product Market Size by Country (2019-2024)
7.4 Europe In Vitro Diagnostics (IVD) Quality Control Product Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Product Market Size (2019-2030)
8.2 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Product Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Product Market Size by Region (2019-2024)
8.4 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Product Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Diagnostics (IVD) Quality Control Product Market Size (2019-2030)
9.2 Latin America In Vitro Diagnostics (IVD) Quality Control Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In Vitro Diagnostics (IVD) Quality Control Product Market Size by Country (2019-2024)
9.4 Latin America In Vitro Diagnostics (IVD) Quality Control Product Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Product Market Size (2019-2030)
10.2 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Product Market Size by Country (2019-2024)
10.4 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Product Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Detail
11.1.2 Bio-Rad Laboratories Business Overview
11.1.3 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.1.4 Bio-Rad Laboratories Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.1.5 Bio-Rad Laboratories Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.2.4 Thermo Fisher Scientific Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Randox Laboratories
11.3.1 Randox Laboratories Company Detail
11.3.2 Randox Laboratories Business Overview
11.3.3 Randox Laboratories In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.3.4 Randox Laboratories Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.3.5 Randox Laboratories Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Detail
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.4.4 Roche Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.4.5 Roche Diagnostics Recent Development
11.5 Abbott Diagnostics
11.5.1 Abbott Diagnostics Company Detail
11.5.2 Abbott Diagnostics Business Overview
11.5.3 Abbott Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.5.4 Abbott Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.5.5 Abbott Diagnostics Recent Development
11.6 Helena Laboratories
11.6.1 Helena Laboratories Company Detail
11.6.2 Helena Laboratories Business Overview
11.6.3 Helena Laboratories In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.6.4 Helena Laboratories Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.6.5 Helena Laboratories Recent Development
11.7 Seracare Life Sciences
11.7.1 Seracare Life Sciences Company Detail
11.7.2 Seracare Life Sciences Business Overview
11.7.3 Seracare Life Sciences In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.7.4 Seracare Life Sciences Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.7.5 Seracare Life Sciences Recent Development
11.8 Technopath Clinical Diagnostics
11.8.1 Technopath Clinical Diagnostics Company Detail
11.8.2 Technopath Clinical Diagnostics Business Overview
11.8.3 Technopath Clinical Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.8.4 Technopath Clinical Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.8.5 Technopath Clinical Diagnostics Recent Development
11.9 Sun Diagnostics
11.9.1 Sun Diagnostics Company Detail
11.9.2 Sun Diagnostics Business Overview
11.9.3 Sun Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.9.4 Sun Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.9.5 Sun Diagnostics Recent Development
11.10 Zeptometrix Corporation
11.10.1 Zeptometrix Corporation Company Detail
11.10.2 Zeptometrix Corporation Business Overview
11.10.3 Zeptometrix Corporation In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.10.4 Zeptometrix Corporation Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.10.5 Zeptometrix Corporation Recent Development
11.11 ISOLAB
11.11.1 ISOLAB Company Detail
11.11.2 ISOLAB Business Overview
11.11.3 ISOLAB In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.11.4 ISOLAB Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.11.5 ISOLAB Recent Development
11.12 Sysmex Corporation
11.12.1 Sysmex Corporation Company Detail
11.12.2 Sysmex Corporation Business Overview
11.12.3 Sysmex Corporation In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.12.4 Sysmex Corporation Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.12.5 Sysmex Corporation Recent Development
11.13 Fortress Diagnostics
11.13.1 Fortress Diagnostics Company Detail
11.13.2 Fortress Diagnostics Business Overview
11.13.3 Fortress Diagnostics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.13.4 Fortress Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.13.5 Fortress Diagnostics Recent Development
11.14 Meril Life Sciences
11.14.1 Meril Life Sciences Company Detail
11.14.2 Meril Life Sciences Business Overview
11.14.3 Meril Life Sciences In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.14.4 Meril Life Sciences Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.14.5 Meril Life Sciences Recent Development
11.15 Multiplicom
11.15.1 Multiplicom Company Detail
11.15.2 Multiplicom Business Overview
11.15.3 Multiplicom In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.15.4 Multiplicom Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.15.5 Multiplicom Recent Development
11.16 Future Diagnostics Solutions
11.16.1 Future Diagnostics Solutions Company Detail
11.16.2 Future Diagnostics Solutions Business Overview
11.16.3 Future Diagnostics Solutions In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.16.4 Future Diagnostics Solutions Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.16.5 Future Diagnostics Solutions Recent Development
11.17 Surmodics
11.17.1 Surmodics Company Detail
11.17.2 Surmodics Business Overview
11.17.3 Surmodics In Vitro Diagnostics (IVD) Quality Control Product Introduction
11.17.4 Surmodics Revenue in In Vitro Diagnostics (IVD) Quality Control Product Business (2019-2024)
11.17.5 Surmodics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
